These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 28705035)

  • 21. Lymphocyte Disturbances in Primary Antiphospholipid Syndrome and Application to Venous Thromboembolism Follow-Up.
    Simonin L; Pasquier E; Leroyer C; Cornec D; Lemerle J; Bendaoud B; Hillion S; Pers JO; Couturaud F; Renaudineau Y
    Clin Rev Allergy Immunol; 2017 Aug; 53(1):14-27. PubMed ID: 27342459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ABO blood types are associated with risk of idiopathic venous thromboembolism in the Korean population. A report from the Korean Venous Thromboembolism Working Party (KVTEWP).
    Jang MJ; Yhim HY; Lee JO; Kim YK; Kim YK; Kim IH; Park S; Choi WI; Oh D; Kim DK; Kim HJ
    Thromb Haemost; 2012 Apr; 107(4):799-801. PubMed ID: 22399152
    [No Abstract]   [Full Text] [Related]  

  • 23. Homocysteine, antiphospholipid antibodies and risk of thrombosis in patients with systemic lupus erythematosus.
    Martínez-Berriotxoa A; Ruiz-Irastorza G; Egurbide MV; Rueda M; Aguirre C
    Lupus; 2004; 13(12):927-33. PubMed ID: 15645748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ABO blood group and thrombotic vascular disease.
    Franchini M; Mannucci PM
    Thromb Haemost; 2014 Dec; 112(6):1103-9. PubMed ID: 25187297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of antiphospholipid antibodies on thrombotic events in ambulatory cancer patients.
    Kansuttiviwat C; Niprapan P; Tantiworawit A; Norasetthada L; Rattarittamrong E; Rattanathammethee T; Hantrakool S; Piriyakhuntorn P; Punnachet T; Hantrakun N; Chai-Adisaksopha C
    PLoS One; 2023; 18(1):e0279450. PubMed ID: 36662720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity. A European multicentre retrospective study.
    Ruffatti A; Salvan E; Del Ross T; Gerosa M; Andreoli L; Maina A; Alijotas-Reig J; De Carolis S; Mekinian A; Bertero MT; Canti V; Brucato A; Bremme K; Ramoni V; Mosca M; Di Poi E; Caramaschi P; Galeazzi M; Tincani A; Trespidi L
    Thromb Haemost; 2014 Oct; 112(4):727-35. PubMed ID: 25008944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody profiles for the diagnosis of antiphospholipid syndrome.
    Pengo V; Biasiolo A; Pegoraro C; Cucchini U; Noventa F; Iliceto S
    Thromb Haemost; 2005 Jun; 93(6):1147-52. PubMed ID: 15968401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiphospholipid antibiodies: a critical review of the literature.
    Lim W; Crowther MA
    Curr Opin Hematol; 2007 Sep; 14(5):494-9. PubMed ID: 17934356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The importance of antiphospholipid syndrome testing in venous thromboembolism after varicose vein surgery.
    Wahl U; Hirsch T
    J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):1097-1101. PubMed ID: 32381473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical implications of the detection of antibodies directed against domain 1 of β2-glycoprotein 1 in thrombotic antiphospholipid syndrome.
    Montalvão S; Elídio PS; da Silva Saraiva S; de Moraes Mazetto B; Colella MP; de Paula EV; Appenzeller S; Annichino-Bizzacchi J; Orsi FA
    Thromb Res; 2016 Dec; 148():32-37. PubMed ID: 27770664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE).
    Ohira T; Cushman M; Tsai MY; Zhang Y; Heckbert SR; Zakai NA; Rosamond WD; Folsom AR
    J Thromb Haemost; 2007 Jul; 5(7):1455-61. PubMed ID: 17425663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distribution of antiphospholipid antibodies in a large population-based German cohort.
    Manukyan D; Rossmann H; Schulz A; Zeller T; Pfeiffer N; Binder H; Münzel T; Beutel ME; Müller-Calleja N; Wild PS; Lackner KJ
    Clin Chem Lab Med; 2016 Oct; 54(10):1663-70. PubMed ID: 27028736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiphospholipid antibodies in critical illness.
    Dentali F; Crowther M
    Crit Care Med; 2010 Feb; 38(2 Suppl):S51-6. PubMed ID: 20083914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of antiphospholipid antibodies and risk of subsequent adverse obstetric outcomes in women with prior pregnancy loss.
    Bowman ZS; Wünsche V; Porter TF; Silver RM; Branch DW
    J Reprod Immunol; 2015 Feb; 107():59-63. PubMed ID: 25453202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of thrombosis in patients with antiphospholipid antibodies and factor V Leiden mutation.
    Pablos JL; Caliz RA; Carreira PE; Atsumi T; Serrano L; Amengual O; Santiago B; Khamashta MA; Hughes GR; Gomez-Reino JJ
    J Rheumatol; 1999 Mar; 26(3):588-90. PubMed ID: 10090167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of antiphospholipid antibody levels and type on thrombotic manifestations: results from the Serbian National Cohort Study.
    Stojanovich L; Markovic O; Marisavljevic D; Elezovic I; Ilijevski N; Stanisavljevic N
    Lupus; 2012 Mar; 21(3):338-45. PubMed ID: 21993381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism.
    Kearon C; Parpia S; Spencer FA; Baglin T; Stevens SM; Bauer KA; Lentz SR; Kessler CM; Douketis JD; Moll S; Kaatz S; Schulman S; Connors JM; Ginsberg JS; Spadafora L; Bhagirath V; Liaw PC; Weitz JI; Julian JA
    Blood; 2018 May; 131(19):2151-2160. PubMed ID: 29490924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ABO Blood Group, SARS-CoV-2 Infection, and Risk of Venous Thromboembolism: Population-Based Cohort Study.
    Ray JG; Vermeulen MJ; Schull MJ; Park AL
    Clin Appl Thromb Hemost; 2021; 27():10760296211008986. PubMed ID: 33827287
    [No Abstract]   [Full Text] [Related]  

  • 39. Risk factors for venous thromboembolism in women under combined oral contraceptive. The PILl Genetic RIsk Monitoring (PILGRIM) Study.
    Suchon P; Al Frouh F; Henneuse A; Ibrahim M; Brunet D; Barthet MC; Aillaud MF; Venton G; Alessi MC; Trégouët DA; Morange PE
    Thromb Haemost; 2016 Jan; 115(1):135-42. PubMed ID: 26290123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The emerging role of multiple antiphospholipid antibodies positivity in patients with antiphospholipid syndrome.
    Forastiero R; Martinuzzo M
    Expert Rev Clin Immunol; 2015; 11(11):1255-63. PubMed ID: 26295486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.